Login

Christophe INIZAN of La Française AM discusses European commercial real estate investment strategies. 00:10:00

Share On Facebook Share On Twitter

Guillaume CADIOU is Chairman of La Française Group

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Focuses on early stage investments in technology companies|Ann Miura-Ko,Co-Founding Partner,Floodgate
00:10:00
Nasdaq Interview Harness The Power of AI with Chad Steelberg | Chad Steelberg, CEO, Veritone IncVERI:NMQ
00:10:00
Company's dual focus in Pharma and Cosmetics, highlighting efficient operations and optimism amidst market volatility | Dr Philippe Wolgen, CEO, Clinuvel Pharmaceuticals Ltd.
00:10:00
The background of a firm or company make a significance difference|Chris Harper,Senior Associate, Torch Capital
00:10:00
Palsatech's Riku Aho Discusses Company Operations on RTL7's 'Business in Europe
00:10:00
Record-Breaking Gold Export Performance in Ghana for 2024
00:10:00
Advancing Energy and Environmental Solutions: Insights from Babcock & Wilcox Executives | Babcock & Wilcox executives; Mohammed Helwee, Regional Director of Business Development and Sales
00:10:00
Panther Metals Ltd. Leadership on ASX Listing and Exploration Targets | Dan Tuffin, CEO, Panther Metals Ltd.
00:10:00
They prefer to invest alongside a lead VC|Gil Shklarski,General Partner,Operator Partners
00:10:00
Global Forces Unveiled: Insights with Lord William Hague | Schroders Investor Download Podcast
00:10:00
Guy Hands on Brexit's Impact: U.K. Exports, Investment Strategy, and ESG in M&A | Guy Hands, Chairman, Terra Firma Capital Partners.
00:10:00
Howard Marks on Debt Investing and the End of Low-Interest Regimes: Insights from Oaktree Capital's Co-Founder and Co-Chairman

© 2017 - Neuhu+